Supportan® has unique formulae with low carbohydrate, high energy, high protein* with fish oil and matches with ESPEN recommendations.
ESPEN guideline recommendations1
Low carbohydrate and high energy: Supportan® DRINK is high fat/ low carbohydrate (40% energy/31% energy). Since cancer cells cannot use fat as source of energy, the formula provides energy to the patients, not the tumour2,4
High protein: Provides 40g protein daily^. Maintain immunity, help repair tissue, compensate for the loss of protein and counteract loss of muscle2,5
Contains EPA: 2g EPA and high protein supplement daily for at least seven week^@. Reduce side effects of therapy5.
Contains antioxidant vitamin: Contain sufficient antioxidant vitamin help wound healing and reduce chance of infections6
Medium chain triglyceride (MCT): Can be absorbed by the body easily and convert into energy2,7
Prebiotic fibre: Water soluble fibre can soften faeces and promote intestinal health2,5
Clinically free from lactose: Prevent diarrhea because of lactose intolerance
Research study
2 bottles of Supportan® DRINK daily can provide 2g of EPA. According to the study9, after 7 weeks with 2g of EPA and high protein supplement per day can increase the weight sigficantly5 , reduce treatment side effect3, maintain immunity10 and finish the treatment according to schedule
Flavours: Cappuccino, Pineapple-Coconut, Tropical Fruits
Format: 200ml in EasyBottle
Recommend dosage:
Nutritional supplement: 2 bottles/ day
Supportan® DRINK is ready to use. Enjoy Supportan® DRINK chilled for the best taste.
A good nutritional status supports the success of medical treatment!
*Based on 2021 market reseach
*ESPEN = The European Society of Clinical Nutrition & Metabolism
^ calculation is based on 2 bottles of Supportan® DRINK per day
@ EPA = Eicosapentaenoic Acid
Reference:
1.Arends J. Bodoky G. Bozzetti F, et al. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clin Nutr. 2006,25:245-259.
2.Supportan® Powder Enteral Nutrition Formula Adapted to the Special Needs of Cancer Patients (Revised on 17th March 2014).
3.Argile’s JM. Cancer-associated malnutrition. Eur J Oncol Nurs. 2005,9 Suppl 2:S39-50.
4.Rossi-Fannelli F, Cascino A, Muscaritoli M. Abnormal substrate metabolism and nutritional strategies in cancer management. JPEN J Parenteral Enteral Nutr. 1991,15:680-683.
5.Mac Donald et al. Understanding and Managing Cancer Cachexia. J Am Coll Surg Vol. 197, No. 1, July 2003
6.American Cancer Society. Benefits of good nutrition during cancer treatment. Available at: www.cancer.org/treatment/survivorshipduringandafterteatment/ nutritionforpeoplewithcancer/nutritionforthepersonwithcancer/nutrition-during-treatment-benefits (Accessed on 7th July, 2014).
7.Chow O&Barbul A. Immnonutrition: Role in Wound Healing and Tissue Regeneration. Adv Wound Care (New Rochelle). 2014,3:46-53.
8.Nagao K & Yangita T. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res. 2010,61:208-212.
9.Barber MD, Ross JA, Voss AC, et al. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999,81:80-86.
10. Muphy RA, et al. Supplementation With Fish Oil Increases First-Line Chemotherpay Effcacy in Patients With Advanced Nonsmall Cell Lung Cancer. Cancer 2011,117:3774-80